A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in Canada

BackgroundThe timely and appropriate adoption of new radiation therapy (RT) technologies is a challenge both in terms of providing of optimal patient care and managing health care resources. Relatively little is known regarding the rate at which new RT technologies are adopted in different jurisdictions, and the barriers to implementation of these technologies.MethodsSurveys were sent to all radiation oncology department heads in Canada regarding the availability of RT equipment from 2006 to 2010. Data were collected concerning the availability and use of Intensity Modulated Radiation Therapy (IMRT) and stereotactic radiosurgery (SRS), and the obstacles to implementation of these technologies.ResultsIMRT was available in 37% of responding centers in 2006, increasing to 87% in 2010. In 2010, 72% of centers reported that IMRT was available for all patients who might benefit, and 37% indicated that they used IMRT for "virtually all" head and neck patients. SRS availability increased from 26% in 2006 to 42.5% in 2010. Eighty-two percent of centers reported that patients had access to SRS either directly or by referral. The main barriers for IMRT implementation included the need to train or hire treatment planning staff, whereas barriers to SRS implementation mostly included the need to purchase and/or upgrade existing planning software and equipment.ConclusionsThe survey showed a growing adoption of IMRT and SRS in Canada, although the latter was available in less than half of responding centers. Barriers to implementation differed for IMRT compared to SRS. Enhancing human resources is an important consideration in the implementation of new RT technologies, due to the multidisciplinary nature of the planning and treatment process.

[1]  David E Morris,et al.  The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. , 2005, International journal of radiation oncology, biology, physics.

[2]  C C Ling,et al.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.

[3]  J. Staffurth,et al.  A review of the clinical evidence for intensity-modulated radiotherapy. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  M. Koizumi,et al.  Japanese structure survey of radiation oncology in 2007 based on institutional stratification of patterns of care study. , 2008, International journal of radiation oncology, biology, physics.

[5]  First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  K Leszczynski,et al.  Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[7]  W. Mayles Survey of the availability and use of advanced radiotherapy technology in the UK. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[8]  J. Sham,et al.  Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.

[9]  P. Warde,et al.  Intensity-modulated radiotherapy in the treatment of breast cancer. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  D P Dearnaley,et al.  Intensity modulated radiation therapy: a clinical review. , 2000, The British journal of radiology.

[11]  John C Roeske,et al.  A survey of intensity‐modulated radiation therapy use in the United States , 2003, Cancer.

[12]  E. B. Butler,et al.  Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. , 2004, International journal of radiation oncology, biology, physics.

[13]  G. Viani,et al.  Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. , 2009, International journal of radiation oncology, biology, physics.

[14]  Y. Yamada,et al.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[15]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[16]  Indira Madani,et al.  Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. , 2008, The Lancet. Oncology.

[17]  J. Williamson,et al.  Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology". , 2008, International journal of radiation oncology, biology, physics.

[18]  Indra J Das,et al.  Analysis of treatment planning time among systems and planners for intensity-modulated radiation therapy. , 2009, Journal of the American College of Radiology : JACR.

[19]  Mark J Dobrow,et al.  Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada , 2011, BMC health services research.

[20]  C. Coles,et al.  A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Norwegian Oncologists' Expectations of Intensity-modulated Radiotherapy , 2002, Acta oncologica.

[22]  C. Anderson,et al.  Radiation Oncology , 2001, Springer International Publishing.

[23]  R. Reznek,et al.  Results of a national survey of radiotherapy planning and delivery in the UK in 2007. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[24]  Wayne Beckham,et al.  A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Geoffrey S Ibbott,et al.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). , 2009, International journal of radiation oncology, biology, physics.

[26]  Fang-Fang Yin,et al.  Advances in Technology for Intracranial Stereotactic Radiosurgery , 2009, Technology in cancer research & treatment.

[27]  Richard Symonds-Tayler,et al.  Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  S. Leung,et al.  Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  M. Williams,et al.  The implementation of intensity-modulated radiotherapy in the UK. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[30]  L. Mell,et al.  Intensity‐modulated radiation therapy use in the U.S., 2004 , 2005, Cancer.

[31]  Lei Xing,et al.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). , 2010, International journal of radiation oncology, biology, physics.

[32]  D. Kondziolka,et al.  The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.

[33]  R. Wong,et al.  Clinical practice guideline on the optimal radiotherapeutic management of brain metastases , 2005, BMC Cancer.

[34]  K. Harrington,et al.  First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  N. Kemeny,et al.  Colorectal hepatic metastases: adjuvant chemotherapy and survival. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.